Erratum to “Significance of topoisomerase IIIβ expression in breast ductal carcinomas: strong associations with disease-specific survival and metastasis” [Hum Pathol 2010;41:1624-1630]

In the above-referenced article, the authors state that all patients underwent surgical excision of the tumor followed by postoperative adjuvant systemic chemotherapy that included 5-fluorouracil, methotrexate, and cyclophosphamide. This is not a correct statement. Actually, patients staged as III were treated with anthracycline-based neoadjuvant chemotherapy and patients staged as IV were not treated with primary surgery. The authors apologize for the incorrect statement.